|Mr. Michael F. Brigham||Pres, CEO, Principal Financial Officer, Treasurer, Sec. & Director||336.88k||N/A||1961|
|Dr. Joseph H. Crabb Ph.D.||VP & Chief Scientific Officer||62k||N/A||1955|
|Ms. Bobbi Jo Brockmann||VP of Sales & Marketing and Director||258.31k||N/A||1977|
|Ms. Elizabeth L. Williams||VP of Manufacturing Operations||240k||N/A||1956|
ImmuCell Corporation, an animal health company, develops, acquires, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. The company offers First Defense, an orally delivered scours preventive product for calves; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. It also provides California Mastitis Test that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic. In addition, the company is involved in developing Re-Tain, a Nisin-based treatment of subclinical mastitis in lactating dairy cows; and offers Dual-Force First Defense, including a whey protein concentrate for the nutritional and feed supplement markets. ImmuCell Corporation sells its products through animal health distributors. The company was founded in 1982 and is headquartered in Portland, Maine.
ImmuCell Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.